BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22045402)

  • 1. Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.
    Bañares R; Catalina MV; Ripoll C; Rincón D
    Dis Markers; 2011; 31(3):165-9. PubMed ID: 22045402
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic evaluation of patients with acute variceal bleeding.
    Augustin S; Millán L; González A; Coll M; Martell M; Genescà J
    Dis Markers; 2011; 31(3):155-64. PubMed ID: 22045401
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of acute variceal bleeding.
    Abraldes JG; Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S312-7. PubMed ID: 17975482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
    Poca M; Puente A; Graupera I; Villanueva C
    Dis Markers; 2011; 31(3):147-54. PubMed ID: 22045400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
    Rockey DC
    Curr Gastroenterol Rep; 2006 Feb; 8(1):7-13. PubMed ID: 16510029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis.
    Feu F; García-Pagán JC; Bosch J; Luca A; Terés J; Escorsell A; Rodés J
    Lancet; 1995 Oct; 346(8982):1056-9. PubMed ID: 7564785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variceal hemorrhage: primary and secondary prophylaxis].
    Sauerbruch T; Schepke M
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S68-70. PubMed ID: 15368173
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
    Kravetz D
    J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S; Bendtsen F
    Ugeskr Laeger; 2010 Dec; 172(49):3411-3. PubMed ID: 21129318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of HVPG measurement: statistics versus clinical applicability.
    Thalheimer U; Leandro G; Mela M; Patch D; Burroughs AK
    Gastroenterology; 2007 Mar; 132(3):1201-2; author reply 1202-4. PubMed ID: 17383448
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endoscopy in primary prophylaxis for esophageal variceal bleeding.
    Albillos A; Peñas B; Zamora J
    Clin Liver Dis; 2010 May; 14(2):231-50. PubMed ID: 20682232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.
    Rosemurgy AS; Serafini FM; Zweibel BR; Black TJ; Kudryk BT; Nord HJ; Goode SE
    J Gastrointest Surg; 2000; 4(6):589-97. PubMed ID: 11307093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.